Cargando…

Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy

BACKGROUND: Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Laurent, Jauffret-Roustide, Marie, Blanche, Jerôme, Maguet, Olivier, Calderon, Christine, Cohen, Julien, Carrieri, Patrizia M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128573/
https://www.ncbi.nlm.nih.gov/pubmed/21619573
http://dx.doi.org/10.1186/1471-2458-11-400
_version_ 1782207451174535168
author Michel, Laurent
Jauffret-Roustide, Marie
Blanche, Jerôme
Maguet, Olivier
Calderon, Christine
Cohen, Julien
Carrieri, Patrizia M
author_facet Michel, Laurent
Jauffret-Roustide, Marie
Blanche, Jerôme
Maguet, Olivier
Calderon, Christine
Cohen, Julien
Carrieri, Patrizia M
author_sort Michel, Laurent
collection PubMed
description BACKGROUND: Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the level of infectious risk by measuring how French prisons adhere to national and WHO guidelines. METHODS: A nationwide survey targeting the heads of medical (all French prisons) and psychiatric (26 French prisons) units was conducted using a postal questionnaire and a phone interview mainly focusing on access to prevention interventions, i.e. bleach, opioid substitution treatment (OST), HBV vaccination and post-exposure prophylaxis (PEP) for French prisoners. Two scores were built reflecting adherence to national and WHO international guidelines, ranging from 0 (no adherence) to 10 (maximum adherence) and 0 to 9 respectively. RESULTS: A majority (N = 113 (66%)) of the 171 prisons answered the questionnaires, representing 74% coverage (46,786 prisoners) of the French prison population: 108 were medical units and 12 were psychiatric units. Inmate access to prevention was poor. The median[IQR] score measuring adherence to national guidelines was quite low (4.5[2.5; 5.5]) but adherence to WHO guidelines was even lower 2.5[1.5; 3.5]; PEP was absent despite reported risky practices. Unsuitable OST delivery practices were frequently observed. CONCLUSIONS: A wide gap exists between HIV prevention policies and their application in prisons. Similar assessments in other countries may be needed to guide a global policy reform in prison settings. Adequate funding together with innovative interventions able to remove structural and ideological barriers to HIV prevention are now needed to motivate those in charge of prison health, to improve their working environment and to relieve French prisoners from their currently debilitating conditions.
format Online
Article
Text
id pubmed-3128573
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31285732011-07-02 Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy Michel, Laurent Jauffret-Roustide, Marie Blanche, Jerôme Maguet, Olivier Calderon, Christine Cohen, Julien Carrieri, Patrizia M BMC Public Health Research Article BACKGROUND: Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national and WHO guidelines provide clear indications on how to reduce this risk. We sought to estimate the level of infectious risk by measuring how French prisons adhere to national and WHO guidelines. METHODS: A nationwide survey targeting the heads of medical (all French prisons) and psychiatric (26 French prisons) units was conducted using a postal questionnaire and a phone interview mainly focusing on access to prevention interventions, i.e. bleach, opioid substitution treatment (OST), HBV vaccination and post-exposure prophylaxis (PEP) for French prisoners. Two scores were built reflecting adherence to national and WHO international guidelines, ranging from 0 (no adherence) to 10 (maximum adherence) and 0 to 9 respectively. RESULTS: A majority (N = 113 (66%)) of the 171 prisons answered the questionnaires, representing 74% coverage (46,786 prisoners) of the French prison population: 108 were medical units and 12 were psychiatric units. Inmate access to prevention was poor. The median[IQR] score measuring adherence to national guidelines was quite low (4.5[2.5; 5.5]) but adherence to WHO guidelines was even lower 2.5[1.5; 3.5]; PEP was absent despite reported risky practices. Unsuitable OST delivery practices were frequently observed. CONCLUSIONS: A wide gap exists between HIV prevention policies and their application in prisons. Similar assessments in other countries may be needed to guide a global policy reform in prison settings. Adequate funding together with innovative interventions able to remove structural and ideological barriers to HIV prevention are now needed to motivate those in charge of prison health, to improve their working environment and to relieve French prisoners from their currently debilitating conditions. BioMed Central 2011-05-27 /pmc/articles/PMC3128573/ /pubmed/21619573 http://dx.doi.org/10.1186/1471-2458-11-400 Text en Copyright ©2011 Michel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Michel, Laurent
Jauffret-Roustide, Marie
Blanche, Jerôme
Maguet, Olivier
Calderon, Christine
Cohen, Julien
Carrieri, Patrizia M
Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
title Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
title_full Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
title_fullStr Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
title_full_unstemmed Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
title_short Limited access to HIV prevention in French prisons (ANRS PRI(2)DE): implications for public health and drug policy
title_sort limited access to hiv prevention in french prisons (anrs pri(2)de): implications for public health and drug policy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128573/
https://www.ncbi.nlm.nih.gov/pubmed/21619573
http://dx.doi.org/10.1186/1471-2458-11-400
work_keys_str_mv AT michellaurent limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy
AT jauffretroustidemarie limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy
AT blanchejerome limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy
AT maguetolivier limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy
AT calderonchristine limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy
AT cohenjulien limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy
AT carrieripatriziam limitedaccesstohivpreventioninfrenchprisonsanrspri2deimplicationsforpublichealthanddrugpolicy